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Abstract
Purpose The objective of this prospective cohort study
was to compare effectiveness, morbidity, quality of life
(QoL) and sexual function in women treated with tension-
free vaginal tape (TVT) versus single-incision sling (SIS)
in the treatment of female stress urinary incontinence
(SUI).
Methods Retropubic TVT sling or SIS was implanted in
local anesthesia and patients were followed post-opera-
tively for 6 months. Evaluation was performed to assess
post-operative rate of continence, complications, changes
in sexual function and patient reported quality of life.
Female sexual function was evaluated before and after
sling procedure using Female Sexual Function Index
(FSFI) in sexually active patients.
Results From January 2009 to December 2011, 150
patients were enrolled and underwent a procedure to
implant the retropubic TVT (n = 75) or the MiniArc and
Ajust SIS (n = 75). Overall, 93.3 % of the patients who
successfully received SIS demonstrated total restoration
(84 %) or improvement of continence (9.3 %) at the 6
month post-operative study visit. In TVT group we found
88 % total continence and 6.7 % improvement, respec-
tively. Improvements were seen in the QoL scores related
to global bladder feeling (89.3 %) in SIS group and 96 %
for TVT. Post-operative FSFI score improves significantly
and were comparable in both groups (SIS pre-operative
24.30 ± 4.56 to 27.22 ± 4.66 (P \ 0.001) post-operative;
TVT 24.63 ± 6.62 to 28.47 ± 4.41, respectively).
Conclusions The SIS procedure appears to be as effective
in improving incontinence-related quality of life and sexual
function as the TVT through 6 months of post-operative
follow-up. No differences in complications and sexual
function were demonstrated between the groups.
Keywords Female Sexual Function Index  Sexual
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Introduction
Urinary incontinence is a prevalent disorder reported by up
to 25 % in women and is highly correlated with impair-
ment of quality of life (QoL) and sexual dysfunction [1, 2].
Curing of incontinence without generating new side effects
(e.g., pain, mesh erosion) may lead to an improvement of
sexual function. Surgical and post-operative complications
such as de novo urgency, pain or dyspareunia negatively
affects sexual function.
Today the minimally invasive mid-urethral slings have
become a standard surgical procedure for surgical treat-
ment of stress urinary incontinence (SUI) in women and
has resulted in a rapid increase in the number of surgeries
performed throughout the last 15 years. Single-incision
slings (SIS) with anchor fixation in the musculus obtura-
torius internus fascia or membrane, such as the MiniArc
and Ajust sling, represent the most recent advancement in
the treatment of SUI. This minimally invasive procedure
leads to less complications with comparable results to
conventional slings [3]. Only few long-term data are
available; 2-year follow-up data from the MiniArc and
Ajust system demonstrate continence for 82–93 % [4–7] of
all patients; no severe side effects were seen.
The effect of suburethral sling on sexual functioning has
been studied, but the results are still inhomogen. Current
literature shows inconsistent data with some studies
reporting improvement [8, 9], some authors reporting
deterioration [10–12] and other noting no change of sexual
function symptoms [13–15].
The aim of our study was first to prospectively evaluate
the effect of surgical procedure for SUI on sexual function
in sexually active patients as well as QoL prospectively;
second to compare the retropubic approach with TVT sling
with single-incision mid-urethral sling procedure MiniArc
and Ajust on this regard. Different approaches of sling
insertion may lead to a different outcome in sexual func-
tion. Minimally invasive access with the avoidance of
relevant anatomical structures, less synthetic material and
missing blind passage of SIS should lead to an improve-
ment of incontincence related disorders as well as sexual
function while preventing conventional surgery related side
effects. Restrictively, using the transobturator approach of
SIS could adversely affect sexual function more than
retropubic way of TVT due to the closer contact to the
dorsal nerve of the clitoris [16].
Materials and methods
In this prospective cohort study, we enrolled patients to a
suburethral sling for female SUI between January 2009 and
December 2011 in our University Department of Obstetrics
and Gynecology. In total, 150 patients were included,
divided into groups for correction of SUI: 75 underwent
insertion of retropubic sling TVT and 75 of transobturator
SIS MiniArc and Ajust. Randomisation of patients for
the use of TVT or SIS sling was done in accordance with
the clinical guidelines of the hospital. Ethical permission
was obtained from the regional ethics committee at Uni-
versity Mainz, Germany and all the patients provided
written informed consent for participation.
Patient recruitment with pre-operative urodynamics and
urogynecologic evaluation was in accordance with to
International Continence Society (ICS) guidelines [17].
All the patients showed pure SUI and normotonic ure-
thra (maximum urethral closure pressure at rest of more
than 20 cm of water in urethral profilometry using an
external fluid-filled catheter).
The retropubic TVT, MiniArc and Ajust sling
procedures were performed as per the manufacturer’s
instructions provided in the instructions for use. TVT sling
was performed as originally described by Ulmsten from
vaginally to above with the complete tension-free place-
ment of sling under the midurethra. Both transobturator SIS
systems are comparable and use special anchors which
fixate the sling on both pelvic sides. Procedures were ini-
tiated with a 1 cm mid-urethral vaginal incision and
preparation of bilateral para-urethral tunnels to the pos-
terior margin of the inferior pubic ramus. Surgeons used a
special thin introducer, loaded with self-fixating anchors, to
pivot around the ischiopubic ramus and insert the anchor
through the obturator internus muscle and obturator
membrane. In all the procedures for TVT and SIS the
performance of cystoscopy were done for the exclusion of
bladder lesions. All sling implantation was performed
under local anesthesia. The Foley catheter was removed
within 24 h after surgery.
Exclusion criteria used were: urge incontinence, mixed
urinary incontinence with dominant urge component,
intrinsic sphincter deficiency, neurogenic bladder (multiple
sclerosis, meningomyelocele, spinal cord injury), symp-
tomatic pelvic organ prolapse, previous incontinence and
prolapse surgery, severe mental illness, severe physical
handicap, poor knowledge of German language and refusal
to consent. To reduce age-related bias, patients over
75 years were excluded.
960 Arch Gynecol Obstet (2013) 287:959–966
123
All women were sexually active; participants who had
no sexual activity within 3 months prior to surgery were
excluded from the study.
Patients were evaluated pre-operatively and 6 months
post-operatively for Female Sexual Function Index (FSFI),
the Patient Perception of Intensity Urgency Scale (PPIUS)
and the Patient Global Impression of Improvement (PGI-I).
Effect of sling surgery on sexual function and the assess-
ment of sexual function, continence and QoL were inves-
tigated prospectively.
Assessing of post-operative rate of continence-related
QoL and changes in sexual function were the primary
objectives of this study. Continence was evaluated by a
standardized cough stress test (CST) with a bladder volume
of approximately 300 ml (confirmed by ultrasound, GE
Voluson-e System); pre- and post-operative FSF scores
were evaluated to determine the changes in sexual func-
tion. Later, we included the evaluation of intra-, peri- and
post-operative complications (bleeding [200 ml, bladder
lesions, erosions, perforations, penetrations, protrusions,
hematomas and bladder outlet obstructions) and patient
QoL.
All women undergoing the TVT or SIS sling procedure
were instructed to complete the FSFI before and after
surgery. The FSFI is a detailed 19-item anonymous ques-
tionnaire including sexual desire (score range 2–10),
arousal (score range 0–20), lubrication (score range 0–20),
orgasm (score range 0–15), satisfaction (score range 2–15),
and pain during sexual intercourse (score range 0–15), as
described by Rosen et al. [18]. A validated German lan-
guage version of the FSFI was used [19]. Total score was
obtained by adding the six domain scores and was calcu-
lated multiplying the sum by the domain. Factors were 0.6
for desire, 0.3 for arousal and lubrication, 0.4 for orgasm,
satisfaction, and pain. Therefore, total FSFI score range
was 2–36 (see Table 1).
Patients also completed the PGI-I, a validated, seven-
item questionnaire used to assess improvement with ther-
apy (very much better, much better, a little better, no
change, a little worse, much worse and very worse) [20].
Urgency was evaluated using the PPIUS which scored
the intensity of urgency at each void with a 5 point scale
[21]. Questionnaires were completed by the patients prior
to clinical examination for baseline and follow-up
assessment.
The data were analyzed at the end of the study using the
Excel program (Microsoft Office Excel 2011). Statistical
analysis was performed using the Statistical Package
For Social Sciences (SPSS, Version 17, Chicago, IL). Nor-
mality testing (Kolmogorow-Smirnow test) was performed to
determine if data were sampled from a normal distribution.
The t test and Mann–Whitney U test were performed
to compare continuous parametric and non-parametric vari-
ables, respectively. The proportion of categorical variables
was analyzed for statistical significance using chi-square test.
Statistical significance was considered to have been reached
when P value was less than 0.05.
Results
From January 2009 to December 2011, 150 patients with
SUI were enrolled in this study and underwent a surgical
procedure to receive the retropubic sling TVT (n = 75) or
single incision sling MiniArc (n = 57) and Ajust
(n = 18) SIS. All the patients completed the scheduled
post-operative 6-month follow-up visit. Demographic and
baseline characteristics are shown in Table 2. There were
no statistically significant differences between both groups
in terms of demographics, pre-operative QoL measures and
urodynamic results.
Perioperative data and outcomes from 6 month visit are
compared in Table 3. None of the patients had concomitant
surgeries and sling implantation was done under intrave-
nous sedation and local anesthesia in all patients. The mean
operating time and complications were comparable in both
groups. All 150 placement procedures were successful, no
complications of bleeding [200 ml, bladder lesions, per-
forations, penetrations, protrusions, hematomas or bladder
outlet obstructions were reported during the study. Oper-
ating time and duration of in-patient treatment were com-
parable in both groups, in previous studies, country specific
reimbursement schedules had influenced the length of
hospitalization for TVT and SIS insertion.
Table 1 FSFI domain scores
and full scale score (18)
Domain Questions Score range Factor Minimum score Maximum score
Desire 1, 2 1–5 0.6 1.2 6.0
Arousal 3, 4, 5, 6 0–5 0.3 0 6.0
Lubrication 7, 8, 9, 10 0–5 0.3 0 6.0
Orgasm 11, 12, 13 0–5 0.4 0 6.0
Satisfaction 14, 15, 16 0 (or 1)–5 0.4 0.8 6.0
Pain 17, 18, 19 0–5 0.4 0 6.0
Full scale score range 2.0 36
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Intraoperative and post-operative pain scores were
consistently low with no cases of groin pain reported post-
operatively and after 6 months of follow-up in both groups.
The overall rate of vaginal sling erosion after surgery
was low (1.3 %) and not significantly different between the
two groups and erosions into the bladder or urethra were
not noted.
Impact on incontinence-related quality of life function
Results for continence are listed in Table 4. At the 6-month
study visit, 63 (84 %) of the 75 patients who received the
SIS-sling demonstrated total restoration with negative CST
or improvement of continence (n = 7; 9.3 %). Five
patients (6.7 %) demonstrated no SUI improvement over
baseline. Subjective continence assessment demonstrated
that 67 (89.3 %) of all 75 patients showed high satisfaction
with subjective continence after surgery. There was no
difference of type of SIS for objective or subjective results.
Seven months after SIS insertion, one patient with no SUI
improvement received another incontinence procedure
with Burch colposuspension after which complete conti-
nence was restored. In the TVT group we found n = 66
(88 %) cases of fully continence with n = 5 (6.7 %)
improvement and n = 4 (5.3 %) cases of failure; 72
patients (96 %) showed high satisfaction concerning post-
operative continence.
PGI-I questionnaire data were collected and reported at
the month 6 study visit. Of the 150 patients 90.7 %
(n = 136) showed a successful outcome with ‘‘very much
better’’ (n = 16) or ‘‘much better’’ (n = 20), with no sta-
tistically significant difference between the two groups
(TVT 92 % versus SIS 89.4 %, p = 0.925) (Table 4).
Post-operatively, patients who received TVT were sig-
nificantly more likely to develop voiding dysfunction and
urgency than those who received a SIS. Data available
from baseline through 6 months of post-operative follow-
up showed significant more urgency in TVT group com-
pared with SIS. Sixty-nine (90.6 %) of the 75 patients who
received a SIS reported PPIUS scores of 0 or 1; indicating
the majority of patients feeling no urgency or being able to
postpone voiding as long as necessary without fear of
wetting at each void, compared to n = 61 (81.3 %) in TVT
group (Table 5).
Based on clinical assessment, PPIUS scores of 2 or
greater were considered abnormal and represented cases of
de novo (new onset) urgency. Five patients in SIS group
experienced moderate urgency (PPIUS score of 2) after the
6-month-follow-up. Two other patients reported severe
urgency. All seven cases were treated with anticholinergic
medications and treatment was ongoing at the end of study
participation. In TVT group significantly more cases of
moderate (n = 12) and severe (n = 2) urgency were
detected (p = 0.003). These patients also needed anticho-
linergic medication in the follow-up.
The majority of the patients in both groups (96 %;
144/150) having PVRs of \100 ml at 1 day post-surgery,
all six women with PVR[100 ml belong to the TVT group
(p \ 0.005). Two women in each group needed operative
release of their sling.
Impact on sexual function
All pre-operative sexually active women reported resump-
tion of sexual activity after sling surgery. Evaluation of






Age (years)a 55.3 (41–72) 54.1 (32–70) 0.415
Paritya 2 (1–4) 2 (0–4) 0.813
Menopause (n) 46 (61.3 %) 39 (52 %) 0.249
Hysterectomy (n) 14 (18.7 %) 17 (22.7 %) 0.539
Hospital stay
(days)a
2.2 (1–3) 2.7 (1–4) 0.422
SIS Single-incision sling, TVT retropubic tension-free vaginal tape
a Median and range










Bladder lesion 0 0 NS
Blood loss [ 200 ml 0 0 NS









Voiding dysfunction (RU [100 ml)




Vaginal erosion 1 1 NS
Tape releasing 2 2 NS
SIS Single-incision sling, TVT retropubic tension-free vaginal tape
a Including time of intraoperative urethrocystoscopy
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sexual function pre-operatively and after 6 month of post-
operative follow-up, FSFI scores showed an improvement
in all domains for the majority of patients. A total of 83
(53.3 %) showed the improvement in total FSFI scores,
whereas 10 patients (6.7 %) showed deteriotation, and 57
patients (38 %) had no changes for FSFI questionaire. These
changes of sexual function were comparable in both groups
(TVT n = 42 improvement and n = 4 deteriotation;
respectively SIS n = 41 improvement and n = 6 deteriota-
tion) without any significant differences.
Comparison of mean pre- and post-operative mean FSFI
scores revealed a significant improvement of the total FSFI
score in both groups in the total score and in all domains at
6 months without significant differences between TVT and
SIS group. Table 6 demonstrates the mean difference between
the baseline and month 6 FSFI scores for both groups.
At month 6, the mean follow-up FSFI total score in SIS
group improved from baseline 24.30 ± 4.56–27.22 ± 4.59
(P \ 0.001), in contrast to the TVT group from baseline
24.63 ± 6.62–28.47 ± 4.41 (P \ 0.001).
Statistically significant increases in post-operative sub-
domains sexual desire, arousal, lubrication, orgasm, satis-
faction and pain also were observed in both groups.
Comparison of post-operative results between TVT and
SIS group in FSFI total and subdomain scores showed no
significant differences; only the subdomains, orgasm and
lubrication showed an advantage for TVT sling (Table 6).
Only one patient in SIS group was suffering from severe
dyspareunia due to sling erosion in the area of colpotomy
with hispareunia of the husband. During a second proce-
dure in local anesthesia the exposed material was resected
and the vaginal wall was closed; dyspareunia resolved. One
patient in TVT group also needed a resection of sling
material due to vaginal erosion with moderate pain.
Discussion
In this prospective study of sexually active women with
SUI QoL, urinary continence and sexual function signifi-
cantly improved after different mid-urethral sling proce-
dures. The insertion of mid-urethral tape has become
common practice for the surgical treatment of female SUI.
Most long-time experiences over years exists for the ret-
ropubic TVT sling system. To avoid complications due to
blind needle passage through the retropubic space (TVT
sling) or transobturator foramen (TOT sling), new SIS
systems were introduced. These slings aim to obtain the
same suburethral support with less invasivity by anchoring
the two arms in the obturator fascia while avoiding the
passage through the adductor muscles.
Clinical reports suggest that SIS is associated with fewer
post-operative complications than the TVT. Two-year
follow-up data of the MiniArc system demonstrated
continence in 82–93 % of treated patients [4, 5] and
12–24 months of follow up in patients treated with Ajust
showed continence up to 83 % of patients with no severe
side effects [6, 7].
In our study both sling systems provide high continence
rates without major complications: 93.3 % in SIS group
and 94.7 % in TVT group with total continence or
Table 4 Evaluation of objective and subjective continence rate and
PGI-I in TVT group and SIS group 6 months post-operatively
SIS group
(n = 75) (%)
TVT group
(n = 75) (%)
Objective continence 63 (84) 66 (88)
Objective improvement 7 (9,3) 5 (6.7)
Objective failure 5 (6,7) 4 (5.3)
Subjective continence and
satisfaction
67 (89.3) 72 (96)
Patient impression of global improvement (PGI-I)
1: very much better 59 (78.7) 57 (76)
2: much better 8 (10.7) 12 (16)
3: a little better 3 (4.0) 2 (2.7)
4: no improvement 4 (5.3) 3 (4.0)
5: a little worse 1 (1.3) 1 (1.3)
6: much worse 0 (0) 0 (0)
7: very much worse 0 (0) 0 (0)
Success* 67 (89.4) 69 (92)
Comparison of mean PGI-I scores
t test for unpaired samples p = 0.925
SIS Single-incision sling, TVT retropubic tension-free vaginal tape,
PGI-I Patient impression of global improvement, Success* ‘very
much better’ and‘ much better’
Table 5 Evaluation of PPIUS in TVT group and SIS group 6 months
post-operatively
PPIUS Rank SIS group
(n = 75) (%)
TVT group
(n = 75) (%)
P value
0: no urgency 61 (81.3) 39 (52)
1: mild urgency 7 (9.3) 22 (29.4)
2: moderate
urgency
5 (6.7) 12 (16)
3: severe urgency 2 (2.7) 1 (1.3)
4: urge
incontinence
0 (0) 1 (1.3)
Mean PPIUS
score (SD)
0.31 (0.716) 0.71 (0.882) 0.003
SIS Single-incision sling, TVT retropubic tension-free vaginal tape,
PPIUS patient perception of intensity of urgency scale
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improvement support equality of data. PGI-I success rates
of 92 % TVT versus 89.4 % in SIS confirm these results. A
6-month follow-up period is very short for the comparison
of objective outcome measures to reveal the benefits of
different sling systems.
De novo urge symptoms have been a problem with the
traditional incontinence operations. Data available from
baseline through month 6 observation showed that the
majority of all sling patients (86 %) felt no urgency or were
able to postpone voiding as long as necessary without fear
of wetting at each void. In the TVT group we found sig-
nificantly more cases of de novo urgency (n = 14, 18.7 %)
in contrast to n = 7 (9.3 %) in SIS group (p = 0.003).
Corresponding findings on the onset of urge symptoms
after TVT surgery have been reported in the literature [22].
Less severe post-operative de novo urgency seen in this
study in SIS group was similar to those seen in other
patients following transobturator mid-urethral sling place-
ment and was also within range of de novo urgency
reported in other SIS Sling studies [3–7].
Sexual dysfunction is more prevalent in women with
urinary incontinence or lower urinary tract symptoms than
in a general, healthy female population, and is highly
prevalent in women suffering from pelvic floor disorders
(10–56 %) [23].
Recent publications evaluating the impact of urinary
incontinence using the FSFI and PISQ have reported con-
flicting results with some reporting detoriation [10, 11], or
no changing of symptoms [12–15].
The effect of surgery for SUI on sexual function has
been controversial. Study design factors including heter-
ogenous patient groups with varying age, hormonal status,
neurological and anatomical factors; retrospective design;
heterogeneity of urogynecological diagnosis with the
coexistence of pelvic organ prolapse; and differences in the
evaluated outcome measures have reduced scientific con-
clusion on this issue.
Results of female sexual function after correction of
incontinence by the TVT have been reported inconsis-
tently. Brubaker et al. [8] showed an improvement of
sexual function, Rogers et al. [10] found declined sexual
function as measured by PISQ in women after TVT despite
the improvement of urinary incontinence at 3–6 months.
Most studies evaluating the effect after retropubic sling
placement showed not only unchanged sexual function [15]
with controversal details in the improvement of symptoms
due to solution of urinary leakage but also deterioration due
to vaginal scaring, tight insertion of the sling or sling
erosion with dyspareunia and partner discomfort.
In our study FSFI total and domain sub-scores in TVT
group demonstrate a significant improvement in sexual
function, only four patients had deterioation of sexuality
after surgery.
Development of the transobturator route for suburethral
sling while avoiding the retropubic space led to decreases in
complication with comparable cure rates and QoL improve-
ment [24]. Recent studies of the transobturator approach also
showed positive effects on sexual function. Studies comparing
retropubic and transobturator sling approaches that assessed
the improvement of post-operative sexual function [9, 25]
noted more pain during intercourse in TOT [26].
Elzevier et al. [27] described a positive effect on sexual
function after outside-in (TOT) and inside-out (TVT-O)
procedure due to continence during intercourse. More pain
Table 6 FSFI domains score of SIS group and TVT group pre-operatively and 6 months follow-up
Desire Arousal Lubrication Orgasm Satisfaction Pain Total
FSFI scores SIS group (n = 75)
Pre-operatively 3.18 ± 0.86 3.81 ± 1.16 4.28 ± 1.36 4.00 ± 1.12 4.72 ± 1.17 4.31 ± 1.25 24.30 ± 4.56
Post-operatively 3.66 ± 0.80 4.37 ± 0.96 4.49 ± 1.33 4.41 ± 0.97 5.27 ± 0.83 5.06 ± 0.99 27.22 ± 4.59
P value \0.001 \0.001 0.009 \0.001 \0.001 \0.001 \0.001
FSFI scores TVT group (n = 75)
Pre-operatively 3.22 ± 0.98 3.94 ± 1.30 4.48 ± 1.45 4.25 ± 1.38 4.58 ± 1.50 4.16 ± 1.42 24.63 ± 6.62
Post-operatively 3.70 ± 0.84 4.46 ± 0.94 5.00 ± 1.12 4.76 ± 1.00 5.29 ± 0.87 5.30 ± 1.00 28.47 ± 4.41
P value \0.001 \0.001 0.003 \0.001 \0.001 \0.001 \0.001
Comparison of FSFI scores post-operatively for TVT and SIS group
SIS group 3.66 ± 0.80 4.37 ± 0.96 4.49 ± 1.33 4.41 ± 0.97 5.27 ± 0.83 5.06 ± 0.99 27.22 ± 4.59
TVT group 3.70 ± 0.84 4.46 ± 0.94 5.00 ± 1.12 4.76 ± 1.00 5.29 ± 0.87 5.30 ± 1.00 28.47 ± 4.41
P value 0.721 0.589 0.012 0.030 0.939 0.143 0.093
t test for independent samples
SIS Single-incision sling, TVT retropubic tension-free vaginal tape
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during intercourse because of vaginal narrowing was
seen significantly more often in the TOT procedure group.
Abdel-Fattah et al. [28] demonstrated an improvement in
94 % after 12 months using TVT-O and TOT, and deteri-
otation in 4.3 %.
First data for sexual function in women with SIS were
presented by Pickens et al. [4] in a study with 108 patients
recieving MiniArc after showing no change after a follow-
up of 12 months. Information was limited due to missing
pre-operative FSFI measurement. In another ongoing study
from our group we found in 73 patients a significant
improvement of sexual function 6 months after SIS inser-
tion using FSFI. Only six patients showed deterioration of
sexual function after sling procedure.
There have been no studies which evaluated the changes
of sexual function in SISs in comparison to other sling
systems like retropubic TVT. In our present study, patients
in SIS and TVT group showed comparable significant
improvement of sexual function after SIS procedure as
evaluated by FSFI. At a 6-month-follow-up the mean FSFI
total score improved from baseline 24.30 ± 4.56 to
27.22 ± 4.59 (P \ 0.001) in SIS group, respectively,
24.63 ± 6.62–28.47 ± 4.41 (P \ 0.001) in TVT group.
All subdomains were changed positively with statistical
power. We could not find real differences in pre-opera-
tively and post-operatively FSFI between both groups.
There was a statistical difference in subdomain orgasm and
lubrication with an advantage to TVT group: for detailed
analysis of this possible difference there is a need for
bigger sample size.
As a more detailed subgroup analysis would need a
bigger sample size and a longer follow-up, we abstained
from generating more sub-groups than the described ones.
Future research should perhaps include a sample size
allowing a more sophisticated subgroup analysis.
Conclusion
Current evidence of pelvic floor surgery on sexual function
is conflicting. Many studies dealing with the changes of
sexual function after incontinence surgery show varying
results.
Single-incision slings seem to be effective and safe in
the operative treatment of female SUI. Six months of fol-
low up data show comparable continence rates for SIS and
TVT without severe side effects or complications. Evalu-
ation in QoL shows the improvement after surgery.
Focusing on sexual function, we could demonstrate sig-
nificant improvement due to TVT and SIS procedure. In
our study, both sling systems are equally effective in
changing continence and sexual function.
Our study warranted several qualifications. To our
knowledge, it is the first prospective comparative evalua-
tion in sexual function for a SIS and TVT sling for treat-
ment of SUI with FSFI pre-operatively and after 6 months
of follow-up. Despite other studies showing no change or
deterioration of sexual function after urogynecological
surgery, our study supports a positive effect of SIS and
TVT on burden of incontinence and sexual dysfunction.
Limitations of this study include a short follow-up with
only 6 months for evaluation of post-operative incontinence.
Furthermore, a 6-month follow-up may be too short to test for
sexual function improvement. The limited number of patients
does not allow the detection of changes in sexual function for
patients who do not reach full post-operative continence to
evaluate urine loss during intercourse. To compare influence
of different slings on changes of sexual function there is need
for more subjects in randomized design. The FSFI questio-
naire does not include questions to explore the relationship
between urinary incontinence and sexual dysfunction and
there are no clear information about incontinence during
intercourse. As the frequency of sexual intercourse turns out to
be reduced and FSFI testing only explores the last 4 weeks,
there might be a ‘‘diagnostic gap’’ concerning sexual function
in the elderly. Female sexual dysfunction is very complex field
and not only caused by pelvic floor disorders.
In conclusion, we found the improvement in inconti-
nence and sexual function after single-incision implace-
ment for SUI similarly to TVT.
Establishing new sling modifications such as SIS
requires not only evaluation of continence; detection of
incontincence-related QoL and sexual function should also
be involved in randomized clinical trials.
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